HOME >> BIOLOGY >> NEWS
Common virus may contribute to uncommon bone disease in children

A common virus may play a major role in causing a painful disease of immune cells that attacks children's bones, according to a new study. The research may eventually lead to an easier diagnosis and to more effective treatments of the disease, Langerhans cell histiocytosis.

Researchers found evidence of the virus, human herpesvirus 6 (HHV-6) in the tissues of 25 of 35 children with Langerhans cell histiocytosis (LCH), compared to virus detected in only five of 19 children without LCH. The research team, led by John P. Dormans, M.D., director of Orthopaedic Surgery at The Children's Hospital of Philadelphia, published its findings in the January/February issue of the Journal of Pediatric Orthopaedics.

Langerhans cells, found in the blood, play an active role in the immune system. An uncontrolled excess of Langerhans cells leads to LCH, with effects that range from a limited, spontaneously resolving illness to a chronic, life-threatening disease involving multiple organ systems. Although rare, occurring in approximately five children per million, LCH most commonly strikes bone, causing painful lesions or fractures.

"LCH is called the 'great imitator' because it resembles particular bone cancers," said Dr. Dormans. "Fortunately, most children survive the disease these days." Most bone lesions resolve on their own without treatment. In other cases, surgeons successfully treat the disease by removing the abnormal area of bone.

However, successful treatment may elude physicians when LCH is chronic and affects multiple systems. Chemotherapy may succeed, at least temporarily, but only for 50 to 60 percent of patients. The cause of LCH remains unknown, and the Children's Hospital researchers investigated its origins, with the goal of advancing treatments.

"It's important to define whether LCH is primarily a tumor-like process or a reactive process, that is, one in which the immune system reacts to an infection or other insult," said M
'"/>

Contact: Joey Marie McCool
McCool@email.chop.edu
267-426-6070
Children's Hospital of Philadelphia
8-Mar-2004


Page: 1 2

Related biology news :

1. Common cold virus can cause polio in mice when injected into muscles
2. Common call for action on European Research Council (ERC)
3. Common therapy for HIV associated with cervical abnormality regression
4. Common chemicals morphing into potential toxins in Arctic
5. Common worm provides insights into salmonella virulence
6. Common airborne substance makes asthmatics more sensitive to house dust mites: study
7. Common genetic damages in non-dividing cells lead to the creation of mutant proteins
8. Common nutrients fed to pregnant mice altered their offsprings coat color
9. Common treatment for depression is safe and effective for Alzheimers patients
10. Common gene variant increases risk of atherosclerosis
11. Common thyroid cancer gene mutation found

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/14/2019)... ... September 12, 2019 , ... ... solutions for drugs, biologics, gene therapies, and consumer health products, today announced that ... biologics business. Dr. Schaffer has played an integral advisory role on the gene ...
(Date:9/8/2019)... Calif. (PRWEB) , ... September 06, 2019 , ... ... Board of Directors of Nanosens Innovations have each authorized the respective companies to ... a subsidiary of Cardea, with the Nanosens brand representing a series of products ...
(Date:8/27/2019)... ... ... Shoreline Biome , a microbiome research company that develops tools for characterizing ... and Karen Woodward as its VP of Business Development. , These two new ... expand the company’s sales worldwide. , Prior to joining Shoreline Biome, Bill McKenzie was ...
Breaking Biology News(10 mins):
(Date:9/17/2019)... ... September 17, 2019 , ... Tucker, a Labrador retriever, was just a puppy ... was limping and lame on his right hip and elbow. At one year of ... “the worst case the vet had seen.” He was prescribed pain medications, both oral ...
(Date:9/17/2019)... ... September 16, 2019 , ... MyBioGate Global ... Focus @ Biotech Week Boston, a forum organized by MyBioGate, Inc. and CUBIO ... , After a careful process of evaluation, twelve companies out of over 200 ...
(Date:9/9/2019)... ... September 09, 2019 , ... Visikol CEO Dr. Michael Johnson ... focused on how best to characterize 3D cell culture models. The inherent problem of ... too thick and opaque to image through and therefore traditional wide-field or even confocal ...
(Date:8/29/2019)... ... August 29, 2019 , ... ... affecting grapevines, a feat they hope will ultimately help protect the multibillion-dollar grape ... several Rochester Institute of Technology faculty and alumni sequenced the microbiome found within ...
Breaking Biology Technology:
Cached News: